<style type="text/css">
    @import url(https://themes.googleusercontent.com/fonts/css?kit=SHJk2CZThnuTXOvq3WlzwLJHFzRtg-vXVIUgH6gCTpzpvX4j4BX5UlQG5AbCKW0-);

    .lst-kix_list_4-1>li {
        counter-increment: lst-ctn-kix_list_4-1
    }

    ol.lst-kix_list_3-1 {
        list-style-type: none
    }

    ol.lst-kix_list_3-2 {
        list-style-type: none
    }

    .lst-kix_list_3-1>li {
        counter-increment: lst-ctn-kix_list_3-1
    }

    ol.lst-kix_list_3-3 {
        list-style-type: none
    }

    ol.lst-kix_list_3-4.start {
        counter-reset: lst-ctn-kix_list_3-4 0
    }

    .lst-kix_list_5-1>li {
        counter-increment: lst-ctn-kix_list_5-1
    }

    ol.lst-kix_list_3-4 {
        list-style-type: none
    }

    .lst-kix_list_2-1>li {
        counter-increment: lst-ctn-kix_list_2-1
    }

    ol.lst-kix_list_3-0 {
        list-style-type: none
    }

    .lst-kix_list_1-1>li {
        counter-increment: lst-ctn-kix_list_1-1
    }

    ol.lst-kix_list_2-6.start {
        counter-reset: lst-ctn-kix_list_2-6 0
    }

    .lst-kix_list_3-0>li:before {
        content: "" counter(lst-ctn-kix_list_3-0, lower-latin) ") "
    }

    ol.lst-kix_list_3-1.start {
        counter-reset: lst-ctn-kix_list_3-1 0
    }

    .lst-kix_list_3-1>li:before {
        content: "" counter(lst-ctn-kix_list_3-1, lower-latin) ". "
    }

    .lst-kix_list_3-2>li:before {
        content: "" counter(lst-ctn-kix_list_3-2, lower-roman) ". "
    }

    ol.lst-kix_list_1-8.start {
        counter-reset: lst-ctn-kix_list_1-8 0
    }

    .lst-kix_list_4-0>li {
        counter-increment: lst-ctn-kix_list_4-0
    }

    .lst-kix_list_5-0>li {
        counter-increment: lst-ctn-kix_list_5-0
    }

    ol.lst-kix_list_2-3.start {
        counter-reset: lst-ctn-kix_list_2-3 0
    }

    .lst-kix_list_3-5>li:before {
        content: "" counter(lst-ctn-kix_list_3-5, lower-roman) ". "
    }

    .lst-kix_list_3-4>li:before {
        content: "" counter(lst-ctn-kix_list_3-4, lower-latin) ". "
    }

    ol.lst-kix_list_1-5.start {
        counter-reset: lst-ctn-kix_list_1-5 0
    }

    .lst-kix_list_3-3>li:before {
        content: "" counter(lst-ctn-kix_list_3-3, decimal) ". "
    }

    ol.lst-kix_list_3-5 {
        list-style-type: none
    }

    ol.lst-kix_list_3-6 {
        list-style-type: none
    }

    ol.lst-kix_list_3-7 {
        list-style-type: none
    }

    ol.lst-kix_list_3-8 {
        list-style-type: none
    }

    .lst-kix_list_3-8>li:before {
        content: "" counter(lst-ctn-kix_list_3-8, lower-roman) ". "
    }

    .lst-kix_list_2-0>li {
        counter-increment: lst-ctn-kix_list_2-0
    }

    ol.lst-kix_list_5-3.start {
        counter-reset: lst-ctn-kix_list_5-3 0
    }

    .lst-kix_list_2-3>li {
        counter-increment: lst-ctn-kix_list_2-3
    }

    .lst-kix_list_3-6>li:before {
        content: "" counter(lst-ctn-kix_list_3-6, decimal) ". "
    }

    .lst-kix_list_4-3>li {
        counter-increment: lst-ctn-kix_list_4-3
    }

    .lst-kix_list_3-7>li:before {
        content: "" counter(lst-ctn-kix_list_3-7, lower-latin) ". "
    }

    ol.lst-kix_list_4-5.start {
        counter-reset: lst-ctn-kix_list_4-5 0
    }

    ol.lst-kix_list_5-0.start {
        counter-reset: lst-ctn-kix_list_5-0 0
    }

    .lst-kix_list_1-2>li {
        counter-increment: lst-ctn-kix_list_1-2
    }

    ol.lst-kix_list_3-7.start {
        counter-reset: lst-ctn-kix_list_3-7 0
    }

    .lst-kix_list_5-2>li {
        counter-increment: lst-ctn-kix_list_5-2
    }

    ol.lst-kix_list_4-2.start {
        counter-reset: lst-ctn-kix_list_4-2 0
    }

    .lst-kix_list_3-2>li {
        counter-increment: lst-ctn-kix_list_3-2
    }

    ol.lst-kix_list_2-2 {
        list-style-type: none
    }

    ol.lst-kix_list_2-3 {
        list-style-type: none
    }

    .lst-kix_list_5-0>li:before {
        content: "" counter(lst-ctn-kix_list_5-0, lower-latin) ") "
    }

    ol.lst-kix_list_2-4 {
        list-style-type: none
    }

    ol.lst-kix_list_2-5 {
        list-style-type: none
    }

    .lst-kix_list_5-4>li {
        counter-increment: lst-ctn-kix_list_5-4
    }

    .lst-kix_list_1-4>li {
        counter-increment: lst-ctn-kix_list_1-4
    }

    .lst-kix_list_4-4>li {
        counter-increment: lst-ctn-kix_list_4-4
    }

    ol.lst-kix_list_2-0 {
        list-style-type: none
    }

    ol.lst-kix_list_1-6.start {
        counter-reset: lst-ctn-kix_list_1-6 0
    }

    ol.lst-kix_list_2-1 {
        list-style-type: none
    }

    .lst-kix_list_4-8>li:before {
        content: "" counter(lst-ctn-kix_list_4-8, lower-roman) ". "
    }

    .lst-kix_list_5-3>li:before {
        content: "" counter(lst-ctn-kix_list_5-3, decimal) ". "
    }

    .lst-kix_list_4-7>li:before {
        content: "" counter(lst-ctn-kix_list_4-7, lower-latin) ". "
    }

    .lst-kix_list_5-2>li:before {
        content: "" counter(lst-ctn-kix_list_5-2, lower-roman) ". "
    }

    .lst-kix_list_5-1>li:before {
        content: "" counter(lst-ctn-kix_list_5-1, lower-latin) ". "
    }

    .lst-kix_list_5-7>li:before {
        content: "" counter(lst-ctn-kix_list_5-7, lower-latin) ". "
    }

    ol.lst-kix_list_5-6.start {
        counter-reset: lst-ctn-kix_list_5-6 0
    }

    .lst-kix_list_5-6>li:before {
        content: "" counter(lst-ctn-kix_list_5-6, decimal) ". "
    }

    .lst-kix_list_5-8>li:before {
        content: "" counter(lst-ctn-kix_list_5-8, lower-roman) ". "
    }

    ol.lst-kix_list_4-1.start {
        counter-reset: lst-ctn-kix_list_4-1 0
    }

    ol.lst-kix_list_4-8.start {
        counter-reset: lst-ctn-kix_list_4-8 0
    }

    ol.lst-kix_list_3-3.start {
        counter-reset: lst-ctn-kix_list_3-3 0
    }

    .lst-kix_list_5-4>li:before {
        content: "" counter(lst-ctn-kix_list_5-4, lower-latin) ". "
    }

    .lst-kix_list_5-5>li:before {
        content: "" counter(lst-ctn-kix_list_5-5, lower-roman) ". "
    }

    ol.lst-kix_list_2-6 {
        list-style-type: none
    }

    ol.lst-kix_list_2-7 {
        list-style-type: none
    }

    ol.lst-kix_list_2-8 {
        list-style-type: none
    }

    ol.lst-kix_list_1-0.start {
        counter-reset: lst-ctn-kix_list_1-0 0
    }

    .lst-kix_list_3-0>li {
        counter-increment: lst-ctn-kix_list_3-0
    }

    .lst-kix_list_3-3>li {
        counter-increment: lst-ctn-kix_list_3-3
    }

    ol.lst-kix_list_4-0.start {
        counter-reset: lst-ctn-kix_list_4-0 0
    }

    .lst-kix_list_3-6>li {
        counter-increment: lst-ctn-kix_list_3-6
    }

    .lst-kix_list_2-5>li {
        counter-increment: lst-ctn-kix_list_2-5
    }

    .lst-kix_list_2-8>li {
        counter-increment: lst-ctn-kix_list_2-8
    }

    ol.lst-kix_list_3-2.start {
        counter-reset: lst-ctn-kix_list_3-2 0
    }

    ol.lst-kix_list_5-5.start {
        counter-reset: lst-ctn-kix_list_5-5 0
    }

    .lst-kix_list_2-2>li {
        counter-increment: lst-ctn-kix_list_2-2
    }

    ol.lst-kix_list_2-4.start {
        counter-reset: lst-ctn-kix_list_2-4 0
    }

    ol.lst-kix_list_4-7.start {
        counter-reset: lst-ctn-kix_list_4-7 0
    }

    ol.lst-kix_list_1-3 {
        list-style-type: none
    }

    ol.lst-kix_list_5-0 {
        list-style-type: none
    }

    ol.lst-kix_list_1-4 {
        list-style-type: none
    }

    .lst-kix_list_2-6>li:before {
        content: "" counter(lst-ctn-kix_list_2-6, decimal) ". "
    }

    .lst-kix_list_2-7>li:before {
        content: "" counter(lst-ctn-kix_list_2-7, lower-latin) ". "
    }

    .lst-kix_list_2-7>li {
        counter-increment: lst-ctn-kix_list_2-7
    }

    .lst-kix_list_3-7>li {
        counter-increment: lst-ctn-kix_list_3-7
    }

    ol.lst-kix_list_5-1 {
        list-style-type: none
    }

    ol.lst-kix_list_1-5 {
        list-style-type: none
    }

    ol.lst-kix_list_5-2 {
        list-style-type: none
    }

    ol.lst-kix_list_1-6 {
        list-style-type: none
    }

    ol.lst-kix_list_1-0 {
        list-style-type: none
    }

    .lst-kix_list_2-4>li:before {
        content: "" counter(lst-ctn-kix_list_2-4, lower-latin) ". "
    }

    .lst-kix_list_2-5>li:before {
        content: "" counter(lst-ctn-kix_list_2-5, lower-roman) ". "
    }

    .lst-kix_list_2-8>li:before {
        content: "" counter(lst-ctn-kix_list_2-8, lower-roman) ". "
    }

    ol.lst-kix_list_1-1 {
        list-style-type: none
    }

    ol.lst-kix_list_1-2 {
        list-style-type: none
    }

    ol.lst-kix_list_5-4.start {
        counter-reset: lst-ctn-kix_list_5-4 0
    }

    ol.lst-kix_list_4-6.start {
        counter-reset: lst-ctn-kix_list_4-6 0
    }

    ol.lst-kix_list_5-1.start {
        counter-reset: lst-ctn-kix_list_5-1 0
    }

    ol.lst-kix_list_3-0.start {
        counter-reset: lst-ctn-kix_list_3-0 0
    }

    ol.lst-kix_list_5-7 {
        list-style-type: none
    }

    ol.lst-kix_list_5-8 {
        list-style-type: none
    }

    .lst-kix_list_5-7>li {
        counter-increment: lst-ctn-kix_list_5-7
    }

    ol.lst-kix_list_4-3.start {
        counter-reset: lst-ctn-kix_list_4-3 0
    }

    ol.lst-kix_list_5-3 {
        list-style-type: none
    }

    ol.lst-kix_list_1-7 {
        list-style-type: none
    }

    .lst-kix_list_4-7>li {
        counter-increment: lst-ctn-kix_list_4-7
    }

    ol.lst-kix_list_5-4 {
        list-style-type: none
    }

    .lst-kix_list_1-7>li {
        counter-increment: lst-ctn-kix_list_1-7
    }

    ol.lst-kix_list_1-8 {
        list-style-type: none
    }

    ol.lst-kix_list_3-8.start {
        counter-reset: lst-ctn-kix_list_3-8 0
    }

    ol.lst-kix_list_5-5 {
        list-style-type: none
    }

    ol.lst-kix_list_5-6 {
        list-style-type: none
    }

    ol.lst-kix_list_2-5.start {
        counter-reset: lst-ctn-kix_list_2-5 0
    }

    .lst-kix_list_5-8>li {
        counter-increment: lst-ctn-kix_list_5-8
    }

    .lst-kix_list_4-0>li:before {
        content: "" counter(lst-ctn-kix_list_4-0, lower-latin) ") "
    }

    .lst-kix_list_2-6>li {
        counter-increment: lst-ctn-kix_list_2-6
    }

    .lst-kix_list_3-8>li {
        counter-increment: lst-ctn-kix_list_3-8
    }

    .lst-kix_list_4-1>li:before {
        content: "" counter(lst-ctn-kix_list_4-1, lower-latin) ". "
    }

    .lst-kix_list_4-6>li {
        counter-increment: lst-ctn-kix_list_4-6
    }

    ol.lst-kix_list_1-7.start {
        counter-reset: lst-ctn-kix_list_1-7 0
    }

    .lst-kix_list_4-4>li:before {
        content: "" counter(lst-ctn-kix_list_4-4, lower-latin) ". "
    }

    ol.lst-kix_list_2-2.start {
        counter-reset: lst-ctn-kix_list_2-2 0
    }

    .lst-kix_list_1-5>li {
        counter-increment: lst-ctn-kix_list_1-5
    }

    .lst-kix_list_4-3>li:before {
        content: "" counter(lst-ctn-kix_list_4-3, decimal) ". "
    }

    .lst-kix_list_4-5>li:before {
        content: "" counter(lst-ctn-kix_list_4-5, lower-roman) ". "
    }

    .lst-kix_list_4-2>li:before {
        content: "" counter(lst-ctn-kix_list_4-2, lower-roman) ". "
    }

    .lst-kix_list_4-6>li:before {
        content: "" counter(lst-ctn-kix_list_4-6, decimal) ". "
    }

    ol.lst-kix_list_5-7.start {
        counter-reset: lst-ctn-kix_list_5-7 0
    }

    .lst-kix_list_1-8>li {
        counter-increment: lst-ctn-kix_list_1-8
    }

    ol.lst-kix_list_1-4.start {
        counter-reset: lst-ctn-kix_list_1-4 0
    }

    .lst-kix_list_5-5>li {
        counter-increment: lst-ctn-kix_list_5-5
    }

    .lst-kix_list_3-5>li {
        counter-increment: lst-ctn-kix_list_3-5
    }

    ol.lst-kix_list_1-1.start {
        counter-reset: lst-ctn-kix_list_1-1 0
    }

    ol.lst-kix_list_4-0 {
        list-style-type: none
    }

    .lst-kix_list_3-4>li {
        counter-increment: lst-ctn-kix_list_3-4
    }

    ol.lst-kix_list_4-1 {
        list-style-type: none
    }

    ol.lst-kix_list_4-4.start {
        counter-reset: lst-ctn-kix_list_4-4 0
    }

    ol.lst-kix_list_4-2 {
        list-style-type: none
    }

    ol.lst-kix_list_4-3 {
        list-style-type: none
    }

    .lst-kix_list_2-4>li {
        counter-increment: lst-ctn-kix_list_2-4
    }

    ol.lst-kix_list_3-6.start {
        counter-reset: lst-ctn-kix_list_3-6 0
    }

    .lst-kix_list_5-3>li {
        counter-increment: lst-ctn-kix_list_5-3
    }

    ol.lst-kix_list_1-3.start {
        counter-reset: lst-ctn-kix_list_1-3 0
    }

    ol.lst-kix_list_2-8.start {
        counter-reset: lst-ctn-kix_list_2-8 0
    }

    ol.lst-kix_list_1-2.start {
        counter-reset: lst-ctn-kix_list_1-2 0
    }

    ol.lst-kix_list_4-8 {
        list-style-type: none
    }

    .lst-kix_list_1-0>li:before {
        content: "" counter(lst-ctn-kix_list_1-0, decimal) ") "
    }

    ol.lst-kix_list_4-4 {
        list-style-type: none
    }

    ol.lst-kix_list_4-5 {
        list-style-type: none
    }

    .lst-kix_list_1-1>li:before {
        content: "" counter(lst-ctn-kix_list_1-1, lower-latin) ". "
    }

    .lst-kix_list_1-2>li:before {
        content: "" counter(lst-ctn-kix_list_1-2, lower-roman) ". "
    }

    ol.lst-kix_list_2-0.start {
        counter-reset: lst-ctn-kix_list_2-0 0
    }

    ol.lst-kix_list_4-6 {
        list-style-type: none
    }

    ol.lst-kix_list_4-7 {
        list-style-type: none
    }

    .lst-kix_list_1-3>li:before {
        content: "" counter(lst-ctn-kix_list_1-3, decimal) ". "
    }

    .lst-kix_list_1-4>li:before {
        content: "" counter(lst-ctn-kix_list_1-4, lower-latin) ". "
    }

    ol.lst-kix_list_3-5.start {
        counter-reset: lst-ctn-kix_list_3-5 0
    }

    .lst-kix_list_1-0>li {
        counter-increment: lst-ctn-kix_list_1-0
    }

    .lst-kix_list_4-8>li {
        counter-increment: lst-ctn-kix_list_4-8
    }

    .lst-kix_list_1-6>li {
        counter-increment: lst-ctn-kix_list_1-6
    }

    .lst-kix_list_1-7>li:before {
        content: "" counter(lst-ctn-kix_list_1-7, lower-latin) ". "
    }

    ol.lst-kix_list_5-8.start {
        counter-reset: lst-ctn-kix_list_5-8 0
    }

    ol.lst-kix_list_2-7.start {
        counter-reset: lst-ctn-kix_list_2-7 0
    }

    .lst-kix_list_1-3>li {
        counter-increment: lst-ctn-kix_list_1-3
    }

    .lst-kix_list_1-5>li:before {
        content: "" counter(lst-ctn-kix_list_1-5, lower-roman) ". "
    }

    .lst-kix_list_1-6>li:before {
        content: "" counter(lst-ctn-kix_list_1-6, decimal) ". "
    }

    li.li-bullet-0:before {
        margin-left: -18pt;
        white-space: nowrap;
        display: inline-block;
        min-width: 18pt
    }

    .lst-kix_list_5-6>li {
        counter-increment: lst-ctn-kix_list_5-6
    }

    .lst-kix_list_2-0>li:before {
        content: "" counter(lst-ctn-kix_list_2-0, decimal) ". "
    }

    .lst-kix_list_2-1>li:before {
        content: "" counter(lst-ctn-kix_list_2-1, lower-latin) ". "
    }

    ol.lst-kix_list_2-1.start {
        counter-reset: lst-ctn-kix_list_2-1 0
    }

    .lst-kix_list_4-5>li {
        counter-increment: lst-ctn-kix_list_4-5
    }

    .lst-kix_list_1-8>li:before {
        content: "" counter(lst-ctn-kix_list_1-8, lower-roman) ". "
    }

    .lst-kix_list_2-2>li:before {
        content: "" counter(lst-ctn-kix_list_2-2, lower-roman) ". "
    }

    .lst-kix_list_2-3>li:before {
        content: "" counter(lst-ctn-kix_list_2-3, decimal) ". "
    }

    .lst-kix_list_4-2>li {
        counter-increment: lst-ctn-kix_list_4-2
    }

    ol.lst-kix_list_5-2.start {
        counter-reset: lst-ctn-kix_list_5-2 0
    }

    ol {
        margin: 0;
        padding: 0
    }

    table td,
    table th {
        padding: 0
    }

    .c21 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 281.4pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c26 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 88.6pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c10 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 88.5pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c19 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 147.6pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c34 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #008000;
        border-top-width: 0pt;
        border-right-width: 0pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 0pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1.5pt;
        width: 147.6pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c24 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1.5pt;
        border-right-width: 0pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 0pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 0pt;
        width: 147.6pt;
        border-top-color: #008000;
        border-bottom-style: solid
    }

    .c33 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 161.3pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c15 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 0pt;
        border-right-width: 0pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 0pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 0pt;
        width: 147.6pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c20 {
        border-right-style: solid;
        padding: 0pt 5.4pt 0pt 5.4pt;
        border-bottom-color: #000000;
        border-top-width: 1pt;
        border-right-width: 1pt;
        border-left-color: #000000;
        vertical-align: top;
        border-right-color: #000000;
        border-left-width: 1pt;
        border-top-style: solid;
        border-left-style: solid;
        border-bottom-width: 1pt;
        width: 221.4pt;
        border-top-color: #000000;
        border-bottom-style: solid
    }

    .c6 {
        -webkit-text-decoration-skip: none;
        color: #000000;
        font-weight: 400;
        text-decoration: underline;
        vertical-align: baseline;
        text-decoration-skip-ink: none;
        font-size: 10pt;
        font-family: "Arial";
        font-style: normal
    }

    .c0 {
        color: #000000;
        font-weight: 400;
        text-decoration: none;
        vertical-align: baseline;
        font-size: 9pt;
        font-family: "Arial";
        font-style: normal
    }

    .c2 {
        color: #000000;
        font-weight: 400;
        text-decoration: none;
        vertical-align: baseline;
        font-size: 10pt;
        font-family: "Arial";
        font-style: normal
    }

    .c28 {
        color: #000000;
        font-weight: 400;
        text-decoration: none;
        vertical-align: baseline;
        font-size: 11pt;
        font-family: "Arial";
        font-style: normal
    }

    .c5 {
        padding-top: 0pt;
        padding-bottom: 0pt;
        line-height: 1.0;
        orphans: 2;
        widows: 2;
        text-align: justify;
        height: 11pt
    }

    .c4 {
        -webkit-text-decoration-skip: none;
        text-decoration: underline;
        vertical-align: baseline;
        text-decoration-skip-ink: none;
        font-size: 10pt;
        font-style: italic
    }

    .c8 {
        padding-top: 0pt;
        padding-bottom: 0pt;
        line-height: 1.0;
        orphans: 2;
        widows: 2;
        text-align: justify
    }

    .c11 {
        padding-top: 0pt;
        padding-bottom: 0pt;
        line-height: 1.0;
        orphans: 2;
        widows: 2;
        text-align: center
    }

    .c7 {
        margin-left: -5.4pt;
        border-spacing: 0;
        border-collapse: collapse;
        margin-right: auto
    }

    .c3 {
        vertical-align: baseline;
        font-size: 10pt;
        font-family: "Noto Sans Symbols";
        font-weight: 400
    }

    .c25 {
        background-color: #ffffff;
        max-width: 468pt;
        padding: 72pt 72pt 72pt 72pt
    }

    .c27 {
        -webkit-text-decoration-skip: none;
        text-decoration: underline;
        text-decoration-skip-ink: none
    }

    .c29 {
        font-family: "Noto Sans Symbols";
        font-weight: 400
    }

    .c1 {
        vertical-align: sub;
        font-size: 10pt
    }

    .c18 {
        font-family: "Noto Sans Symbols";
        font-style: italic
    }

    .c39 {
        vertical-align: sub;
        font-size: 9pt
    }

    .c9 {
        vertical-align: baseline;
        font-size: 10pt
    }

    .c31 {
        vertical-align: super;
        font-size: 9pt
    }

    .c14 {
        padding: 0;
        margin: 0
    }

    .c38 {
        font-weight: 400;
        font-family: "Arial"
    }

    .c36 {
        vertical-align: baseline;
        font-size: 15pt
    }

    .c23 {
        margin-left: 36pt;
        padding-left: 0pt
    }

    .c13 {
        vertical-align: super;
        font-size: 10pt
    }

    .c17 {
        vertical-align: baseline;
        font-size: 9pt
    }

    .c37 {
        color: #000000;
        font-style: normal
    }

    .c30 {
        height: 11pt
    }

    .c12 {
        height: 0pt
    }

    .c22 {
        font-style: italic
    }

    .c35 {
        font-family: "Noto Sans Symbols"
    }

    .c16 {
        font-weight: 700
    }

    .c32 {
        margin-left: 18pt
    }
</style>

<p class="c11"><span class="c27 c16 c36">Peptides Notes</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16">The Basics</span></p>
<p class="c8"><span class="c9 c22 c16">The Proteinogenic </span><span class="c9 c16 c18">&alpha;</span><span
        class="c9 c22 c16">-amino acids</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 337.80px; height: 52.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image72.png"
            style="width: 337.80px; height: 52.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p><a id="t.8cc1b9e31e305b81a1b03770222ab1342293e570"></a><a id="t.0"></a>
<table class="c7">
    <tr class="c12">
        <td class="c24" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">Amino Acid</span></p>
        </td>
        <td class="c24" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">Abbreviation</span></p>
        </td>
        <td class="c24" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">Side Chain (R)</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Glycine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Gly</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">H</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Alanine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Ala</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Me</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Valine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Val</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CHMe</span><span class="c1">2</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Leucine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Leu</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CHMe</span><span
                    class="c1">2</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Isoleucine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Ile</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH(Me)CH</span><span class="c1">2</span><span class="c2">Me</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Phenylalanine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Phe</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">Ph</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Tyrosine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Tyr</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">(4-hydroxyphenyl)</span>
            </p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Tryptophan</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Trp</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">(3-indolyl)</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Methionine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Met</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CH</span><span
                    class="c1">2</span><span class="c2">SMe</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Cysteine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Cys</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">SH</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Serine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Ser</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">OH</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Threonine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Thr</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">CH(Me)OH</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Arginine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Arg</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CH</span><span
                    class="c1">2</span><span class="c9">CH</span><span class="c1">2</span><span
                    class="c9">NHC(=NH)NH</span><span class="c1">2</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Lysine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Lys</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">(CH</span><span class="c1">2</span><span class="c9">)</span><span
                    class="c1">4</span><span class="c9">NH</span><span class="c1">2</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Histidine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">His</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c2">(4-imidazolyl)</span>
            </p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Glutamic Acid</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Glu</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CH</span><span
                    class="c1">2</span><span class="c9">CO</span><span class="c1">2</span><span class="c2">H</span>
            </p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Aspartic Acid</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Asp</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CO</span><span
                    class="c1">2</span><span class="c2">H</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Glutamine</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Gln</span></p>
        </td>
        <td class="c15" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CH</span><span
                    class="c1">2</span><span class="c9">CONH</span><span class="c1">2</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c34" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Asparagine</span></p>
        </td>
        <td class="c34" colspan="1" rowspan="1">
            <p class="c11"><span class="c2">Asn</span></p>
        </td>
        <td class="c34" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">CH</span><span class="c1">2</span><span class="c9">CONH</span><span
                    class="c1">2</span></p>
        </td>
    </tr>
</table>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Peptides</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 255.80px; height: 133.60px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image74.png"
            style="width: 255.80px; height: 133.60px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">What they do:</span></p>
<p class="c8"><span class="c2">Hormones &ndash; insulin and oxytocin.</span></p>
<p class="c8"><span class="c2">Antibiotics &ndash; penicillin.</span></p>
<p class="c8"><span class="c2">Drugs &ndash; zoladex (prostate cancer), crixivan (AIDS).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Structure Determination</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Usually by chemical degradation, although Physical Methods can also be used.</span>
</p>
<p class="c5"><span class="c2"></span></p>
<ol class="c14 lst-kix_list_1-0 start" start="1">
    <li class="c8 c23 li-bullet-0"><span class="c2">Oxidise S-S bridges with peracid.</span></li>
</ol>
<p class="c5 c32"><span class="c2"></span></p>
<ol class="c14 lst-kix_list_1-0" start="2">
    <li class="c8 c23 li-bullet-0"><span class="c9">C-terminal: </span><span class="c9 c16">hydrazinolysis</span>
    </li>
</ol>
<p class="c11 c32"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 393.13px; height: 69.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image73.png"
            style="width: 393.13px; height: 69.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<ol class="c14 lst-kix_list_1-0" start="3">
    <li class="c8 c23 li-bullet-0"><span class="c2">N-terminal:</span></li>
</ol>
<p class="c8 c32"><span class="c9 c16">Sanger Method &ndash;</span></p>
<p class="c11 c32"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 301.07px; height: 134.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image76.png"
            style="width: 301.07px; height: 134.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8 c32"><span class="c9 c16">Edman Method &ndash;</span></p>
<p class="c11 c32"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 332.67px; height: 132.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image75.png"
            style="width: 332.67px; height: 132.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<ol class="c14 lst-kix_list_1-0" start="4">
    <li class="c8 c23 li-bullet-0"><span class="c2">Selective Fragmentation &ndash; add BrCN at Met residues.</span>
    </li>
</ol>
<p class="c11 c32"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 384.67px; height: 61.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image79.png"
            style="width: 384.67px; height: 61.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<ol class="c14 lst-kix_list_1-0" start="5">
    <li class="c8 c23 li-bullet-0"><span class="c2">Protease Enzymes, e.g. trypsin (cleaves basic side chains
            &ndash; Lys, Arg).</span></li>
</ol>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">4 &amp; 5 are often combined &ndash; overlap sequences and thus helps structure
        assignment.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Synthesis Overview</span></p>
<p class="c8"><span class="c2">Unsymmetrical dipeptides:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 348.13px; height: 47.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image77.png"
            style="width: 348.13px; height: 47.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Need to protect them selectively &ndash;</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 282.47px; height: 181.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image81.png"
            style="width: 282.47px; height: 181.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Depicted as:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 177.00px; height: 105.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image80.png"
            style="width: 177.00px; height: 105.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Protecting Groups</span></p>
<ol class="c14 lst-kix_list_2-0 start" start="1">
    <li class="c8 c23 li-bullet-0"><span class="c2">Easy to introduce.</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Protect Functional Group during amide formation.</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Removable without harming rest of the molecule.</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">No loss of stereochemistry in 1-3.</span></li>
</ol>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16 c35">&alpha;</span><span class="c4 c16">-amino Protection</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Alkoxycarbonyl Protection</span></p>
<p class="c8"><span class="c2">Also known as urethanes or carbamates. They are both amides and esters. As amides,
        they have low nucleophilic reactivity at nitrogen. As esters, they have relatively low reactivity wrt
        acyl-oxygen fission, but they can be degraded alkyl-oxygen fission to carbamic acids, which decarboxylate
        spontaneously under practically all conditions, regenerating the parent amine.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">They are also good because they are nearly immune to racemisation.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Benzyloxycarbonyl (Z)</span></p>
<p class="c8"><span class="c2">Less reactive acylating agents (i.e. not the chloroformate) are sometimes preferred
        to prevent dipeptide formation:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 394.20px; height: 106.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image84.png"
            style="width: 394.20px; height: 106.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Hence use reagents such as:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 165.07px; height: 69.47px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image82.png"
            style="width: 165.07px; height: 69.47px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Mildly basic or nucleophilic reagents do not generally affect the Z group at ambient
        temperature. The main exception to this is hydantoin formation:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 332.07px; height: 87.47px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image83.png"
            style="width: 332.07px; height: 87.47px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">However, this is only really significant with ZXaaGly-peptides.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Mildly acidic conditions (e.g. half an hour with neat TFA in an ice-bath) are also
        without effect. This allows it to be carried through synthesis with more acid-labile protecting groups
        (orthogonality).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">Cleavage conditions are HBr/AcOH or catalytic hydrogenolysis. HBr/AcOH proceeds by an
        S</span><span class="c1">N</span><span class="c13">2</span><span class="c2">-like mechanism:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 337.00px; height: 88.40px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image85.png"
            style="width: 337.00px; height: 88.40px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">The conditions are quite severe though, but most peptides survive it undamaged,
        unless susceptible side-chains are present. This is usually due to the generation of electrophilic species
        such as benzyl cations which attack electron-rich side chains (e.g. Trp, Tyr, Met). Additives like anisole
        and DMS diminish this difficulty by acting as &ldquo;scavengers&rdquo; for such species. Increasing the
        acidity of the conditions tends to favour an S</span><span class="c1">N</span><span class="c13">1</span><span
        class="c9">&nbsp;mechanism, where electrophile generation is more of a problem.
        Typical Scavengers are triethyl silane (Et</span><span class="c1">3</span><span class="c9">SiH), which is
        attacked by CF</span><span class="c1">3</span><span class="c9">COO</span><span class="c13">-</span><span
        class="c2">&nbsp;and donates its H to the electrophile, converting it to a harmless hydrocarbon.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Catalytic hydrogenolysis is a useful alternative providing S side-chains are not
        present, as the sulphur contaminates the catalyst.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">t-Butoxycarbonyl (Boc)</span></p>
<p class="c8"><span class="c2">t-butyl chloroformate decomposes too easily to prepare Boc derivatives. The azide was
        used for some time, but now the anhydride is preferred (less explosive). The only disadvantage with this is
        cost.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 231.13px; height: 39.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image86.png"
            style="width: 231.13px; height: 39.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 207.07px; height: 47.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image87.png"
            style="width: 207.07px; height: 47.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The Boc group is completely stable to catalytic hydrogenolysis conditions, but is
        much more acid labile than the Z group, so it is highly orthogonal to this.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Basic and nucleophilic reagents have no effect at all on the Boc group, even on
        prolonged exposure. No hydantoin formation.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Removal is facile with TFA (either neat or diluted) at ambient temperature for about
        half an hour.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 391.33px; height: 118.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image88.png"
            style="width: 391.33px; height: 118.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The t-butyl moiety ends up as isobutene unless it is trapped by a nucleophile, so
        scavengers are often added (these are essential if sensitive residues such as Trp are present). Mineral
        acids attack Boc groups rapidly, and must be avoided in acidification and wash procedures (use citric acid
        wash &ndash; weak acid and does not extract into organic solvents from water).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">2-(4-biphenylyl)-isopropoxycarbonyl (Bpoc)</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 229.80px; height: 76.53px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image89.png"
            style="width: 229.80px; height: 76.53px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Even more acid labile than Boc (biphenylyl adds stabilisation to carbocation
        generated). Can remove in the presence of Boc by brief treatment with chloroacetic acid-dichloromethane
        mixtures. It is also cleaved by catalytic hydrogenolysis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">9-fluorenylmethoxycarbonyl (Fmoc)</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 190.93px; height: 90.27px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image90.png"
            style="width: 190.93px; height: 90.27px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Introduced in a Schotten-Baumann manner, using FmocCl. Dipeptide formation is a risk,
        so several less reactive reagents such as FmocOSu may be used.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">Fmoc is very stable to acid, but cleaved swiftly under certain basic conditions.
        Piperidine (20% in DMF) is the routine reagent, but fluoride ions in DMF also work. The mechanism is very
        rapid, and proceeds via E</span><span class="c1">1cb</span><span class="c2">&nbsp;via the stabilised
        anion:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 277.47px; height: 216.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image91.png"
            style="width: 277.47px; height: 216.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">This does not affect Boc or Z groups, or most other protecting groups in fact. Fmoc
        is not completely inert to catalytic hydrogenolysis, so this should be avoided for Z removal in the presence
        of Fmoc.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Alloc</span></p>
<p class="c8"><span class="c2">This is another orthogonal option. It is added using the chloroformate, but usefully
        can be removed by Pd catalysts as shown.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 116.87px; height: 84.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image92.png"
            style="width: 116.87px; height: 84.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 232.13px; height: 85.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image62.png"
            style="width: 232.13px; height: 85.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Other Methods</span></p>
<p class="c8"><span class="c2">There are several useful protecting groups that are not alkoxycarbonyl based.</span>
</p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Triphenylmethyl (trityl, Trt)</span></p>
<p class="c8"><span class="c9">Reaction with </span><span class="c3">&alpha;</span><span class="c2">-amino esters
        gives better yields than Trt-Cl directly. However, this is sluggish, so the following method is usually
        used:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 370.20px; height: 74.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image63.png"
            style="width: 370.20px; height: 74.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The trityl group is very stable to base, very labile to acid (acetic acid of pH 4
        works), and does not survive catalytic hydrogenolysis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Only problem is the extreme bulk can cause difficulties in peptide bond
        formation.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">2-nitrophenylsulphenyl (Nps)</span></p>
<p class="c8"><span class="c2">NpsCl + amino acid are not very stable in the free acid state, so they are generally
        isolated, purified and stored as dicyclohexylammonium salts. They can be liberated by cautious acidification
        with sulphuric acid. Nps group is stable to mild base, but not to acid or catalytic hydrogenolysis.</span>
</p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">Sulphenamides deactivate the nucleophilic reactivity at the amino nitrogen by S-N
    </span><span class="c3">&pi;</span><span class="c9">-bonding effects, and it is backed up the electron
        withdrawing NO</span><span class="c1">2</span><span class="c2">&nbsp;substituent.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Deprotection proceeds as follows:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 256.33px; height: 124.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image64.png"
            style="width: 256.33px; height: 124.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c4">Dithiasuccinoyl (Dts)</span></p>
<p class="c8"><span class="c9">Add EtOCS</span><span class="c1">2</span><span class="c9">Me, then ClSOCl, then
        aqueous acid to amino ester. The chemistry is complicated (and smelly) but it has one advantage &ndash; it
        can be selectively removed by treatment with thiol RSH and a mild base such as Et</span><span
        class="c1">3</span><span class="c2">N.</span></p>
<p class="c5"><span class="c3 c27 c37"></span></p>
<p class="c11"><span class="c4 c35 c16">&alpha;</span><span class="c4 c16">-Carboxy Protection</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The carboxy does not always need protecting (it is less nucleophilic than the amine)
        but often is for solubility advantages and product isolation. The usual means of protection is
        esterification, and the carboxy group can be regenerated on alkyl-oxygen fission.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Esters</span></p>
<p class="c8"><span class="c4">Methyl and Ethyl Esters</span></p>
<p class="c8"><span class="c2">Amino acids react with hot methanolic hydrogen chloride. Can also use thionyl
        chloride + methanol. They provide good protection, surviving most peptide bond forming procedures, but as a
        consequence are hard to remove. For example, HBr/AcOH does not affect them, nor does catalytic
        hydrogenation. Saponification is sometimes satisfactory but has the risk of racemisation and side reactions
        such as hydantoin formation. Hydrazinolysis can also be used, but not entirely reliable either.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Side reactions are also possible at the dipeptide stage, because dipeptide methyl
        ester free bases cyclise to diketopiperazines (DKPs) rather easily:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 312.87px; height: 88.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image66.png"
            style="width: 312.87px; height: 88.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c4">Benzyl Esters</span></p>
<p class="c8"><span class="c9">Amino Acid + TsOH + BzlOH over heat gives H</span><span class="c1">3</span><span
        class="c9">N</span><span class="c13">+</span><span class="c9">CHRCO</span><span class="c1">2</span><span
        class="c2">Bzl. Driven by removal of water. Isolated as salts, as the free bases are unstable (and prone to
        DKP formation, above). </span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">They can be cleaved by hydrazinolysis or saponification, but also by catalytic
        hydrogenolysis, HBr/AcOH, but not TFA. Their response to acidic media is thus similar to the Z group (also a
        benzyl ester).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">t-Butyl Esters</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 388.93px; height: 64.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image67.png"
            style="width: 388.93px; height: 64.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">These are stable in the free base for (t-butyl ester inert to nucleophilic and basic
        attack). The stability and lability of these generally parallels the Boc group, as would be expected, so TFA
        will cleave it.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Phenyl Esters</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 357.33px; height: 52.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image68.png"
            style="width: 357.33px; height: 52.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">The group is incompatible with standard coupling and isolation routines. It is
        completely stable to acidic media (hence its development) as well as catalytic hydrogenolysis. Alkali causes
        cleavage more rapidly than with methyl esters, but it is the extraordinary susceptibility to attack by the
        peroxide ion which makes the method attractive. Mechanism presumably generates the peracid, but this is
        unstable with the </span><span class="c3">&alpha;</span><span class="c2">-electron withdrawing group
        present, so it collapses to the desired carboxylic acid.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Phenacyl Esters</span></p>
<p class="c8"><span class="c9">-CO</span><span class="c1">2</span><span class="c9">CH</span><span
        class="c1">2</span><span class="c9">COPh. Formation by reaction of carboxylate with phenacyl bromide,
        BrCH</span><span class="c1">2</span><span class="c2">COPh. Stable in dry acidic conditions, and removable by
        zinc-acetic acid (orthogonal to t-Bu and Benzyl based protecting groups).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16">Peptide Bond Formation</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">With very few exceptions, peptide bond forming procedures involving the generation
        and aminolysis of reactive carboxy derivatives are employed. Activation, i.e. the attachment of a leaving
        group to the acyl carbon of the carboxy component, is necessary because carboxylic acids form salts with
        amines at ambient temperature.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">There are three different ways of coupling along these lines:</span></p>
<ol class="c14 lst-kix_list_3-0 start" start="1">
    <li class="c8 c23 li-bullet-0"><span class="c2">Those in which a reactive acylating agent is formed from the
            carboxy component in a separate step or steps, followed by treatment with the amino component,</span>
    </li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Those in which an isolable acylating agent is formed separately,
            and may be purified before aminolysis, and</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Those in which the acylating intermediate is generated in the
            presence of the amino component, by the addition of an activating agent to a mixture of the two
            components.</span></li>
</ol>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The activation is usually achieved by reaction of the carboxy component with an
        electrophilic reagent, either by adding:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 318.33px; height: 99.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image69.png"
            style="width: 318.33px; height: 99.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Or by substitution:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 354.73px; height: 162.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image70.png"
            style="width: 354.73px; height: 162.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Activation and Coupling</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Acyl Chlorides and Fluorides</span><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.00px; height: 213.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image19.png"
            style="width: 144.00px; height: 213.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Conversion of acylamino acids to acyl chlorides, followed by reaction with amino
        acids or esters under Schotten-Baumann conditions is an obvious approach.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 311.13px; height: 36.47px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image71.png"
            style="width: 311.13px; height: 36.47px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">The reagents traditionally used for formation of the acyl chloride are thionyl
        chloride, PCl</span><span class="c1">5</span><span class="c2">, or similar. These are, however, too vigorous
        to be compatible with complex or sensitive substrates, and there is the risk of cyclisation to give
        oxazolones and hence racemic peptides.</span></p>
<p class="c11 c30"><span class="c2"></span></p>
<p class="c8"><span class="c2">Z amino acid chlorides are isolable but unstable, decomposing to N-carboxyanhydrides
        on warming (path a), although they cyclise to give benzyloxyoxazolones under basic conditions (path b). This
        position was altered dramatically by the discovery of Fmoc amino acid chlorides and also fluorides are easy
        to prepare, and are rather stable convenient intermediates.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 317.27px; height: 45.47px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image11.png"
            style="width: 317.27px; height: 45.47px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">Fmoc amino acid fluorides can be obtained from Fmoc amino acid pyridine salts by
        treatment with cyanuric fluoride, a procedure which does not disturb t-butyl type protecting groups. Acyl
        fluorides are more stable than the corresponding acyl chlorides to neutral oxygen nucleophiles such as
        water, and to tertiary bases, but they show similar high reactivity to amino groups. They are of particular
        value for forming peptide bonds between sterically hindered amino acids such as </span><span
        class="c3">&alpha;</span><span class="c2">-aminoisobutyric acid (Aib).</span><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 82.00px; height: 72.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image3.png"
            style="width: 82.00px; height: 72.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Acyl Azides</span></p>
<p class="c8"><span class="c2">Made from hydrazides, which are obtained by hydrazinolysis of a protected amino acid
        or peptide ester, or by selective deprotection of a peptide derivative which has been constructed using a
        blocked hydrazide for carboxy-terminal protection. Conversion to the azide can be achieved by adding sodium
        nitrite in HCl(aq), but dry acid + nitrite ester in a dry organic solvent at lower temperature is now
        preferred.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 352.47px; height: 134.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image12.png"
            style="width: 352.47px; height: 134.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">There are numerous side reactions possible with this procedure though (e.g. Curtius
        rearrangement to RNCO), so the azide method has not been used routinely for stepwise peptide building for a
        while. It remained a technique for segment condensation, as the procedure is free from racemisation.
        Racemisation only ever occurs with excess base in polar solvents, but it remains the least likely method for
        this to occur.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Anhydrides</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c6">Symmetrical Anhydrides</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 267.80px; height: 46.60px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image13.png"
            style="width: 267.80px; height: 46.60px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Aminolysis of these is unambiguous, but only half the carboxy component is
        incorporated into the product. They are otherwise clean acylating agents, with the exception of Z-glycine
        derivatives being unstable on heating or with base. They are very useful in stepwise synthesis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c6">Mixed Anhydrides with Carboxylic Acids</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 423.87px; height: 58.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image14.png"
            style="width: 423.87px; height: 58.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Main problems with this method are that the anhydride has two similar electrophilic
        sites and can therefore undergo aminolysis ambiguously, and also these reagents tend to disproportionate,
        ultimately with the same result.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 365.20px; height: 134.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image15.png"
            style="width: 365.20px; height: 134.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">However, the selectivity can be improved greatly by introducing steric hindrance and
        inductive depression of electrophilicity, so as to direct the attack to the carboxy component carbonyl, as
        in mixed pivalic anhydrides:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 389.87px; height: 71.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image16.png"
            style="width: 389.87px; height: 71.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Mixed Pivalic Anhydrides are commonly used as they are stable wrt disproportionation,
        and can be isolated in some cases. Pivaloyl derivatives of the amino component are occasionally obtained,
        but this is not normally a serious matter, and the method is a valuable alternative to the mixed carbonic
        anhydride method.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c6">Mixed Anhydrides with Carbonic Acids</span></p>
<p class="c8"><span class="c2">This is the most popular of the anhydride methods.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 402.07px; height: 126.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image17.png"
            style="width: 402.07px; height: 126.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Ethyl chloroformate is commonly used, but isobutyl chloroformate is also popular. The
        flanking of one of the carbonyl groups by two oxygen atoms diminishes reactivity, so that nucleophilic
        attack is directed towards the carbonyl of the original carboxy component.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Low temperatures and minimal activation times are usually employed:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 398.60px; height: 60.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image18.png"
            style="width: 398.60px; height: 60.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">They can be isolated, although there is some decomposition at ambient temperature.
        The timescale for these reactions is measured in hours rather than minutes. Conditions for the minimisation
        of racemisation have been delineated for model cases, but the technique has not found wide application for
        fragment condensation at racemisable residues, as less risky procedures are available.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The value of the method lies in its speed and economy, and it has been used in
        repetitive stepwise synthesis with some success, up to medium chain length. Its most common use is in simple
        protected peptides in the tri- to hexapeptide range, as these have solubility properties uncomfortably
        similar to those of dicyclohexylurea (making DCCI methods tiresome).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">To avoid the need for separate activation and aminolysis steps, mixed ethyl carbonic
        anhydrides can be generated by the reaction below of carboxylic acids with
        1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ):</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 234.60px; height: 139.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image20.png"
            style="width: 234.60px; height: 139.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">EEDQ can also be used as a direct coupling reagent:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 263.80px; height: 38.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image1.png"
            style="width: 263.80px; height: 38.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Because in this technique the mixed carbonic anhydride is consumed by aminolysis as
        soon as it is formed, the opportunity for the intervention of side-reactions, including racemisation, is
        minimal. Workup is also simple.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c6">Mixed Anhydrides with diphenylphosphinic acid</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 342.87px; height: 77.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image2.png"
            style="width: 342.87px; height: 77.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">This method is more regioselective than the other mixed anhydrides, as aminolysis
        occurs exclusively at the carbonyl of the activated amino acid residue, even when steric factors might
        militate otherwise. Coupling is thus very clean and workup is simple.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Carbodiimide Reagents</span></p>
<p class="c8"><span class="c2">Dicyclohexylcarbodiimide (DCCI) has been the single most important reagent for
        activating carboxy groups in peptide synthesis ever since it was reported in 1955. It can be used to
        generate activated carboxy derivatives such as symmetrical anhydrides (as earlier) and active esters (see
        later), or as a direct coupling reagent. In all cases, the primary activating event is addition of the
        carboxy group to the carbodiimide functionality to give an O-acylisourea, which is a potent acylating
        agent.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 285.27px; height: 171.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image4.png"
            style="width: 285.27px; height: 171.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Direct peptide coupling with DCCI is in principle very simple, involving mere mixing
        of the amino and carboxy components with DCCI in equimolecular amounts in an organic solvent at ambient
        temperature. O-acylisourea formation is rapid, leading to peptide either by immediate aminolysis or via a
        symmetryical anhydride, with the concomitant formation of dicylcohexylurea.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 349.40px; height: 131.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image5.png"
            style="width: 349.40px; height: 131.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The urea is only sparingly soluble in most solvents, so its separation is facile in
        solution synthesis, while being soluble enough to remove through washing in solid phase synthesis.</span>
</p>
<p class="c8"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 98.33px; height: 129.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image78.png"
            style="width: 98.33px; height: 129.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">However, the intermediates shown are highly reactive, and side reactions can
        intervene, especially if the amino component is dilatory. Extensive racemisation takes place with
        susceptible carboxy components. Furthermore, the collapse of the O-acylisourea by intramolecular acyl
        transfer sometimes competes significantly with the desired attack by external nucleophiles. When this
        happens, the much less reactive N-acylurea below is formed. This can also be formed by intermolecular
        reaction between the urea and a symmetrical anhydride, especially in DMF.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">N-acylurea formation not only reduces the yield, but may give rise to purification
        problems. This difficulty, and the danger of racemisation, can both be greatly reduced by performing the
        coupling in the presence of a suitable </span><span class="c3">&alpha;</span><span class="c2">-nucleophile
        which is able to react very rapidly with the O-acylisourea before side-reactions can intervene. An acylating
        agent of lower potency is formed, which is still reactive with respect to aminolysis, but which is more
        discriminating and does not lead to racemisation or other side-reactions.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Numerous possible additives, which in effect generate an active ester in situ, are
        used. N-hydroxysuccinimide was the first, but 1-hydroxybenzotriazole (HOBt) has been the one most regularly
        used so far. The recently introduced aza and monocyclic analogues HOAt and HOCt may prove to be
        superior.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 237.20px; height: 106.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image6.png"
            style="width: 237.20px; height: 106.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 412.67px; height: 119.60px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image7.png"
            style="width: 412.67px; height: 119.60px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c4">Phosphonium and (so-called) Uronium Reagents</span></p>
<p class="c8"><span class="c2">Acyloxyphosphonium species react readily with nucleophiles at the acyl carbon.</span>
</p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 303.27px; height: 64.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image8.png"
            style="width: 303.27px; height: 64.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">Benzotriazolyloxy-tris-(dimethylamino) phosphonium hexafluorophosphate, alias the BOP
        reagent, is the main one. It has the formula (Me</span><span class="c1">2</span><span class="c9">N)</span><span
        class="c1">3</span><span class="c9">P</span><span class="c13">+</span><span class="c9">--OBt,PF</span><span
        class="c1">6</span><span class="c13">-</span><span class="c2">. For
        coupling, an equivalent of the reagent is added to a 1:1 mixture of the amino and carboxy components,
        together with a tertiary base to ensure that the latter is ionic. Many pathways are possible, but the main
        one is via the ester of HOBt:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 355.07px; height: 115.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image9.png"
            style="width: 355.07px; height: 115.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">All the co-products are easily removed, and the procedure gives high yields with few
        side-reactions, even in difficult cases. As the initial step is anion-cation reaction, it is favoured in
        less polar solvent. It is also applicable in both solution and solid phase.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">New reagents termed TBTU and HATU are replacing this on grounds of toxicity.</span>
</p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 220.87px; height: 173.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image10.png"
            style="width: 220.87px; height: 173.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">These are obtained from HOBt / HOAt respectively, by reacting them with
        tetramethylchloroformadinium cation (Me</span><span class="c1">2</span><span class="c9">N)</span><span
        class="c1">2</span><span class="c9">C</span><span class="c13">+</span><span class="c2">--Cl (made from
        phosgene or oxalyl chloride on tetramethylurea). </span><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 103.07px; height: 113.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image65.png"
            style="width: 103.07px; height: 113.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">TBTU and HATU are termed uronium salts, despite the fact that they are actually
        guanidinium derivatives in the solid state. In solution the two forms may coexist. HATU seems to be the best
        reagent in this class, succeeding in sterically hindered couplings and giving minimal racemisation. The high
        reactivity to amino groups is probably due to intramolecular general base catalysis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Mechanism &ndash;</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 304.73px; height: 153.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image32.png"
            style="width: 304.73px; height: 153.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Note that another Direct Coupling Reagent, Woodward&rsquo;s Reagent K, is also often
        used:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 276.40px; height: 226.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image33.png"
            style="width: 276.40px; height: 226.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c4">Active Esters</span></p>
<p class="c8"><span class="c2">Active esters offer excellent leaving groups attached to the carbonyl, for rapid
        aminolysis. They are usually prepared by DCCI-mediated coupling:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 212.00px; height: 64.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image34.png"
            style="width: 212.00px; height: 64.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Mixed anhydride methods can also be used, and various specialised reagents are
        available:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 372.93px; height: 168.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image35.png"
            style="width: 372.93px; height: 168.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The currently popular active esters are generally crystalline, stable
        materials.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 277.40px; height: 108.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image36.png"
            style="width: 277.40px; height: 108.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Because they are at a low level of activation, side-reactions during coupling
        (including racemisation) are generally less of a problem than with most peptide bond forming procedures,
        although there is a serious risk of racemisation when active esters are prepared directly if the carboxy
        component is susceptible, especially if exposure to base is involved. </span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The appeal lies in the cleanliness of the reaction, allowing easy repetition which
        dispense with isolation of intermediate peptides. The more reactive active esters are also valuable in solid
        phase synthesis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The reactivities of the various active esters correlates broadly with the acidities
        of the ester moieties, after allowance for sterics etc. Pfp and Su are especially reactive. Co-product
        removal is also a consideration.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">N-carboxyanhydrides</span></p>
<p class="c8"><span class="c9">The N-carboxy anhydrides (NCAs) of </span><span class="c3">&alpha;</span><span
        class="c9">-amino acids are easily obtained by the action of phosgene of </span><span
        class="c3">&alpha;</span><span class="c9">-amino acids, or by thermal decomposition of
        alkoxycarbonyl-</span><span class="c3">&alpha;</span><span class="c2">-amino acid chlorides. They are useful
        in two modes.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">First, treatment with small amounts of nucleophilic initiator in an organic solvent
        leads to successive ring opening and loss of carbon dioxide, giving a new nucleophile which attacks another
        molecule of NCA, and so on, leading to the formation of homopolyamino acid:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 361.07px; height: 164.33px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image37.png"
            style="width: 361.07px; height: 164.33px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Second, providing the conditions are carefully controlled, NCAs can be used for rapid
        peptide synthesis in aqueous solution:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 360.27px; height: 68.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image38.png"
            style="width: 360.27px; height: 68.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Extension to short oligopeptides is possible by repetition, e.g.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 400.40px; height: 66.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image39.png"
            style="width: 400.40px; height: 66.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The peptides prepared via NCAs in this way are of high optical purity, and in
        principle the great rapidity of the technique and the possibility of using a repetitive regime makes it very
        attractive.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">However, the carbamic acids produced by aminolysis of NCAs are unstable, and some
        decarboxylation usually occurs before the aminolysis stage is complete, giving a fresh amino group which can
        react with any remaining NCA and result in &ldquo;over-reaction&rdquo;. Minimisation of this and other
        side-reactions requires exceedingly careful control of the reaction conditions, and the progressive
        accumulation of over-reaction products limits the extent to which the repetitive approach can be taken
        without prohibitive purification problems.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">NCAs can be N-alkoxycarbonylated in the presence of base to give urethane-protected
        NCAs (UNCAs). Fmoc-NCAs, for example, are generally useful and can be kept for some time, and react rapidly
        and cleanly with amino groups to give Fmoc-aminoacyl derivatives and carbon dioxide as the only
        co-product:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 209.87px; height: 86.87px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image40.png"
            style="width: 209.87px; height: 86.87px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Racemisation</span></p>
<p class="c8"><span class="c2">In peptide chemistry this term covers not only conversion of enantiomers but also
        partial epimerisation, whereby there is loss of chiral integrity at one of two or more chiral centres,
        resulting in the formation of a mixture of epimers (i.e. diastereoisomers differing at one chiral
        centre).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">It is an almost exclusively base-induced side-reaction, and in practice is only a
        matter for serious concern at the activation and coupling stages of a synthesis. There are two principal
        mechanisms.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Direct Enolisation</span></p>
<p class="c8"><span class="c9">Deprotonation at the </span><span class="c3">&alpha;</span><span class="c9">-carbon
        of an </span><span class="c3">&alpha;</span><span class="c2">-amino acid residue result in racemisation,
        because the carbanion can reprotonate on either side:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 197.80px; height: 88.40px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image31.png"
            style="width: 197.80px; height: 88.40px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">When the group attached to the carbonyl is NH, O-alkyl or O</span><span
        class="c13">-</span><span class="c2">, it is in most cases negligible, so deprotection is safe. During
        activation and coupling, however, the risk is more significant. Racemisation is fastest when
        electron-withdrawing groups are in the position next to the carbonyl (i.e. good leaving groups) and with
        unhindered strong bases in dipolar aprotic solvents like DMSO and DMF. Fortunately, with the exception of a
        few special amino acids and couplings which are extremely slow, the amount of racemisation which takes place
        is very slight.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">The Oxazolone Mechanism</span></p>
<p class="c8"><span class="c2">Activated acylamino acids and peptides cyclise under the influence of base to give
        oxazolones. These are themselves activated towards aminolysis, and reaction with amino components leads
        ultimately to peptides, but since their racemisation via stabilised anions is usually fast compared to the
        rate of peptide bond formation, any peptide produced is largely useless.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 364.33px; height: 132.27px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image23.png"
            style="width: 364.33px; height: 132.27px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">When the amino-nitrogen of the activated residue is acylated with a simple acyl group
        (acetyl, benzoyl, etc), or with a peptide chain, cyclisation to the oxazolone occurs easily with most good
        leaving groups X, and gross or even complete racemisation may ensue. But oxazolone formation is not so
        facile when the acyl substituent is an alkoxycarbonyl protecting group. This is vitally important, and
        explains the extensive use of alkoxycarbonyl protection.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Use of Enzymes</span></p>
<p class="c8"><span class="c2">Advantages here are the mild conditions, freedom from racemisation and the need for
        side-chain protection, and scope for industrial scale-up.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Disadvantages &ndash; unpredictability. Also, not all the appropriate proteases are
        available, and non-proteinogenic amino acids are obviously problematic.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16">Residue-Specific Considerations</span></p>
<p class="c11 c30"><span class="c6"></span></p>
<p class="c8"><span class="c9 c22 c16">Lysine</span></p>
<p class="c8"><span class="c9">Block the </span><span class="c3">&epsilon;</span><span class="c9">-amino group on
        the side-chain prior to peptide bond formation. Can be achieved using the fact that the side-chain amino
        group is the more basic and nucleophilic because there is an electron-withdrawing group next to the
    </span><span class="c3">&alpha;</span><span class="c9">-amino group, or by taking advantage of the fact that two
    </span><span class="c3">&alpha;</span><span class="c2">-functionalities can engage in chelate formation.</span>
</p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 285.80px; height: 90.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image24.png"
            style="width: 285.80px; height: 90.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Once the amino groups have been distinguished, trivial reactions give ready access to
        any required orthogonally disubstituted lysines, e.g.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 252.13px; height: 109.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image25.png"
            style="width: 252.13px; height: 109.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Arginine</span></p>
<p class="c8"><span class="c9">Guanidino side-chain is a strong base which remains protonated under normal
        conditions for </span><span class="c3">&alpha;</span><span class="c2">-protection, peptide bond formation,
        and deprotection. Thus, it can be left unprotected. However, may give rise to solubility problems, so
        protection is often carried out. The classic method is nitration:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 312.33px; height: 72.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image26.png"
            style="width: 312.33px; height: 72.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Note that there are risks of side-reactions in base (cyclisation).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Aspartic and Glutamic Acids</span></p>
<p class="c8"><span class="c9">Peptide bond formation involving </span><span class="c3">&alpha;</span><span
        class="c2">-carboxy groups requires that the carboxy groups on these side chains must be protected
        (obviously!). Benzyl or t-butyl ester protection is usually employed.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">Differentiation of the carboxy groups is again based on reactivity &ndash; the
    </span><span class="c3">&alpha;</span><span class="c2">-carboxy is deactivated to esterification by a nearby
        protonated amino group.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Main difficulties lie in the ease of cyclic imide and amide ring formation, and may
        be one of the most serious side-reactions in peptide synthesis:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 368.73px; height: 98.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image27.png"
            style="width: 368.73px; height: 98.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">It is less serious with secondary and tertiary alkyl esters in the side-chain than it
        is with esters of primary alcohols. 5-membered ring cyclisation is more rapid, so it is less of a problem
        for glutamic acid.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Cysteine and Cystine</span></p>
<p class="c8"><span class="c2">Unique case, due to disulphide bridge formation. Until we want these to form, the
        thiol groups must be protected, because they interfere with many routine operations. They are soft
        nucleophiles, so selective S-protection by direct alkylation is easy.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 407.40px; height: 278.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image28.png"
            style="width: 407.40px; height: 278.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">None of the S-protecting groups are compatible with ordinary catalytic
        hydrogenolysis, but H</span><span class="c1">2</span><span class="c9">/Pd in liquid ammonia may be used for
        removing Z from Cys(Bzl) derivatives. Mild acid and base </span><span class="c3">&alpha;</span><span
        class="c2">-deprotective procedures may be used in conjunction.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Forming disulphide bridges can be carried out by oxidation of unprotected thiols, or
        more usually now without deprotection, by iodine oxidation of bis-trityl peptides.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 310.27px; height: 57.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image29.png"
            style="width: 310.27px; height: 57.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">The reaction probably proceeds as follows:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 213.07px; height: 104.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image30.png"
            style="width: 213.07px; height: 104.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">For more than one disulphide bridge in a molecular, fragmentation tactics must be
        used, or selective deprotection of the appropriate thiols in turn.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Methionine</span></p>
<p class="c8"><span class="c9">This is problematic because the thioether side-chain interferes with catalytic
        hydrogenation, and is liable to be attacked by electrophiles generated on acidolytic deprotection of other
        functionalities. The usual response is, however, to live with it, adjusting the conditions chosen
        accordingly. Protection by reversible oxidation to the sulphoxide with H</span><span class="c1">2</span><span
        class="c9">O</span><span class="c1">2</span><span class="c2">&nbsp;is favoured by
        some.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c16 c22">Serine, Threonine, Tyrosine</span></p>
<p class="c8"><span class="c2">Hydroxy groups, especially phenolic ones, react with acylating agents, and are
        therefore usually protected in peptide synthesis. They can sometimes be left without in conditions of mild
        carboxy-activation. Benzyl ether protection, cleaved by vigorous acidolysis or catalytic hydrogenolysis, or
        t-butyl ether protection (TFA cleavage) are standard.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Asparagine and Glutamine</span></p>
<p class="c8"><span class="c9">Amide side-chains are usually left unprotected, despite poor solubility and risk of
        side-reactions. Trityl protection is sometimes used in conjunction with Fmoc </span><span
        class="c3">&alpha;</span><span class="c2">-protection, as it is easily removed by mild acid at the end, but
        resists catalytic hydrogenolysis and base.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Histidine</span></p>
<p class="c8"><span class="c2">The basic and nucleophilic side-chain requires protection. Racemisation is
        particularly prevalent, as is attack on DCCI, and formation of acyl-imidazoles.</span><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.80px; height: 307.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image61.png"
            style="width: 144.80px; height: 307.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">As shown, the trityl group is currently the protecting group of choice, placed at the
    </span><span class="c17 c29">&tau;</span><span class="c9">-position. Racemisation is still a problem due to the
        free </span><span class="c3">&pi;</span><span class="c9">-position. In conjunction with Boc </span><span
        class="c3">&alpha;</span><span class="c9">-protection, </span><span class="c3">&pi;</span><span
        class="c2">-benzyloxymethyl (Bom) protection is ideal &ndash; it resists TFA, but is cleaved by HF or
        HBr/AcOH and (less reliably) by catalytic hydrogenolysis.</span></p>
<p class="c8"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 416.27px; height: 143.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image21.png"
            style="width: 416.27px; height: 143.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Tryptophan</span></p>
<p class="c8"><span class="c2">The indole ring does not interfere with peptide bond formation, but captures
        electrophiles with great ease at several sites, especially the 2-position, meaning scavengers for
        deprotection of acid labile protecting groups are essential.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Proline</span></p>
<p class="c8"><span class="c2">The special structure of proline gives it two impediments in synthesis (steric
        hindrance to acylation, susceptibility of Xaa-Pro bonds to reduction by sodium in ammonia), but also gives
        it a resistance to base-catalysed racemisation which is unique among the chiral protein building blocks.
        From a strategic point of view, this is a vital fact, because it allows any coupling from a proline carboxy
        group, including an acylpeptide fragment, to be performed without racemisation.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The ordinary oxazolone racemisation mechanism pathway is not possible because they
        have no NH. Cyclisation to an oxazolonium cation can take place, and such cations are optically labile, but
        much more vigorous conditions are required than are ever used in peptide synthesis.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Glycine, Phenylalanine, Alanine, Leucine, Isoleucine, Valine</span></p>
<p class="c8"><span class="c2">No side chain functionality. Alanine and Leucine are trouble-free.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Glycine, achiral and without any side chain, is sometimes difficult to deal with,
        because the unimpeded access to peptide bonds involving it allows side reactions such as hydantoin
        formation. The same consideration facilitates strong interchain H-bonding, which tends to make peptides with
        a high glycine content rather insoluble.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Phenylalanine is only a problem if catalytic hydrogenolysis reaction times are too
        long (is reduced to cyclohexylalanine).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Valine and Isoleucine couple slowly (steric reasons) &ndash; allows side-reactions to
        compete.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16">Strategy and Tactics</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Stepwise Elongation Strategy &ndash; e.g. for a tripeptide, [1+(2+3)] is the same as
        [(1+2)+3].</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">For a tetrapeptide, however, there are five strategies. Four of these are formally
        stepwise, but one is convergent, i.e. two dipeptides are connected together. This has implications for
        yield. Assuming there is an 80% yield at each stage, then stepwise elongation gives a total yield of 52%,
        while convergent (fragment) methods gives 64%. </span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">There are also further advantages to the fragment condensation approach. Firstly, if
        small fragments are combined to make one which is larger, the differences between the desired product and
        everything else ought to facilitate its isolation, whereas the addition of residues one at a time would
        result only in progressive small changes in chemical character and molecular size, with consequently greater
        isolation and purification problems. Secondly, in a fragment condensation approach, personnel can be
        assigned each of their fragments to work simultaneously in parallel.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">However, there are contrary considerations. Fragment condensation is better performed
        at some positions than others, so it is a constrained strategy, and its protective group tactics are in
        general more complicated than those of a stepwise synthesis strategy from the carboxy end.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">For a classical solution synthesis, the optimum approach is usually stepwise
        synthesis of fragments for assembly in an overall convergent strategy.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The principal strategic constraint in the desirability of proceeding in such a way as
        to minimise the risk of racemisation throughout. There is no real risk except at the activated amino acid
        residue during the activation and peptide bond formation stages. Furthermore, if the azide or DCCI/HOBt
        procedures are used, racemisation is usually slight, with small peptides at least. The situation is
        summarised more fully below:</span></p>
<p class="c5"><span class="c2"></span></p><a id="t.75aed6fc3f148e213407ee131e39082e51d1b616"></a><a id="t.1"></a>
<table class="c7">
    <tr class="c12">
        <td class="c19" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">A - Safe</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">B - Usually Safe</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c11"><span class="c9 c16">C - Unsafe</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c19" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Activation and coupling of any alkoxycarbonyl-amino acid by any
                    conventional method</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Activation and coupling of any carboxy component by the azide method
                    (unless coupling sluggish)</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Activation and coupling of any carboxy component not in column A by any
                    method not in column B</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c19" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Activation and coupling of acyl-peptidylglycines and
                    acylpeptidyl-prolines by any conventional method</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Activation and coupling of any carboxy component by the DCCI/HOBt method
                    or a variant</span></p>
        </td>
        <td class="c19" colspan="1" rowspan="1">
            <p class="c5"><span class="c0"></span></p>
        </td>
    </tr>
</table>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Advances in separation technology (e.g. countercurrent techniques) are taking place
        that minimise these risks further.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Generalising about synthesis strategies is usually not possible. The presence of
        disulphide bridges usually needs to be considered first. Problematic residues such as Met or Trp are
        preferably introduced late in the synthesis. It is also wise to consider whether fragments will end up being
        unreactive or insoluble.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The number and distribution of glycine and proline residues are important in the
        design of a fragment condensation strategy. This is because it prevents oxazolone formation when glycine is
        the C-terminus (see earlier). Also, proline locks the conformation (as does a disulphide bridge) preventing
        the cyclisation. For example, a fragment strategy for AlaGlyGluMetGluOH should be devised based on splitting
        between Gly and Glu, so that racemisation is avoided. Hence, Z-Ala-Gly-OMe and
        Boc-Glu(OBzl)-Met-Glu(OBzl)-OMe would be combined.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">N to C strategies are usually highly undesirable. This is due to the fundamental flaw
        that 5-membered ring formation is favoured, i.e. oxazolone formation is a problem. Hence, carbamate
        protection is preferred as this prevents this happening, i.e. want C to N strategy.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Protecting Group Tactics</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Consider the target GlyLysGly, which is best approached by the stepwise
        strategy:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 390.67px; height: 220.13px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image22.png"
            style="width: 390.67px; height: 220.13px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">The minimum requirement is that protecting group P</span><span class="c13">2</span><span
        class="c9">&nbsp;is orthogonal to P</span><span class="c13">1</span><span class="c9">&nbsp;and P</span><span
        class="c13">3</span><span class="c9">. P</span><span class="c13">2</span><span class="c2">&nbsp;is termed the
        temporary protecting group.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">The most important tactical approaches using well-tried protecting groups are
        shown:</span></p>
<p class="c5"><span class="c2"></span></p><a id="t.bd80a2ceadb6d630e8024c06fe7ca729a669313d"></a><a id="t.2"></a>
<table class="c7">
    <tr class="c12">
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Tactics</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">A</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">B</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">C</span></p>
        </td>
        <td class="c26" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">D</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Temporary </span><span class="c3">&alpha;</span><span
                    class="c2">-amino</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Z</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Boc</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Bpoc</span></p>
        </td>
        <td class="c26" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Fmoc</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Cleaving temporary</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">H</span><span class="c1">2</span><span class="c2">/cat</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Mild acid</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Very mild acid</span></p>
        </td>
        <td class="c26" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Basic</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Permanent protection</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Boc, OBu</span><span class="c13">t</span><span class="c2">, etc</span>
            </p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Z, OBzl, etc.</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Boc, OBu</span><span class="c13">t</span><span class="c2">, etc</span>
            </p>
        </td>
        <td class="c26" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Boc, OBu</span><span class="c13">t</span><span class="c2">, etc</span>
            </p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Cleaving permanent</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Mild acid</span></p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Strong acid or H</span><span class="c1">2</span><span class="c2">/cat</span>
            </p>
        </td>
        <td class="c10" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Mild acid</span></p>
        </td>
        <td class="c26" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Mild acid</span></p>
        </td>
    </tr>
</table>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">The above also represents a solid phase synthesis if P</span><span
        class="c13">1</span><span class="c2">&nbsp;is the resin carrier, which can be regarded as the C-terminal
        permanent protecting group. In fact, B and D are the Merrifield and Sheppard methods (see later).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Tactics are more complicated for fragment condensation strategies. For example,
        Lys(Boc)Lys(Boc) insertion between two other fragments, to make &ndash;COLys(Boc)Lys(Boc)NH-, there are a
        number of options:</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Salt coupling &ndash;</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 379.20px; height: 254.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image53.png"
            style="width: 379.20px; height: 254.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Methyl Ester &ndash;</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 179.53px; height: 135.00px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image54.png"
            style="width: 179.53px; height: 135.00px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 231.07px; height: 164.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image55.png"
            style="width: 231.07px; height: 164.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Remember also that side chains (like Lys above) may need protecting. This was
        discussed earlier.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span class="c4 c16">Solution Peptide Synthesis</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Best described by examples.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">Oxytocin</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 495.93px; height: 350.33px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image56.png"
            style="width: 495.93px; height: 350.33px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Also, an entirely different approach:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 481.73px; height: 313.93px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image57.png"
            style="width: 481.73px; height: 313.93px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Porcine Gastrin I</span></p>
<p class="c8"><span class="c2">Fragment condensation strategy adopted, with three main fragments of comparable size,
        which were chosen to exclude Met from the central fragment (allowing the use of hydrogenolysis). Fragment
        conjunction performed at points dictated by racemisation.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 308.87px; height: 208.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image58.png"
            style="width: 308.87px; height: 208.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 375.87px; height: 265.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image59.png"
            style="width: 375.87px; height: 265.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 349.87px; height: 198.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image60.png"
            style="width: 349.87px; height: 198.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 460.47px; height: 264.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image50.png"
            style="width: 460.47px; height: 264.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Human Insulin</span></p>
<p class="c8"><span class="c2">This is made up of two chains:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 431.40px; height: 201.53px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image51.png"
            style="width: 431.40px; height: 201.53px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">It is tricky to join the chains by the disulphide bridges in the correct places. A
        suitable synthesis is shown below. The key features are the selective removal of a trityl in the presence of
        Bpoc, the use of sulphenyl thiocarbonate method to make the unsymmetrical two-chain disulphide starting
        material, and the selective formation of a disulphide bridge between two Cys(Trt) residues in the presence
        of Cys(Acm).</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 366.93px; height: 176.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image52.png"
            style="width: 366.93px; height: 176.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 358.20px; height: 306.80px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image43.png"
            style="width: 358.20px; height: 306.80px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 303.13px; height: 379.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image44.png"
            style="width: 303.13px; height: 379.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c11"><span class="c4 c16">Solid Phase Peptide Synthesis</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">First detailed by Merrifield in 1963. The principle is outlined below:</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 372.27px; height: 372.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image45.png"
            style="width: 372.27px; height: 372.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">&ldquo;Solid&rdquo; phase is a little misleading &ndash; it takes place in swollen
        gel system produced by the penetration of solvent and solute molecules right into the polymeric matrix. The
        technique has been scaled up to industrial levels (highly automated).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9 c22 c16">The Merrifield Approach</span></p>
<p class="c8"><span class="c2">Polystyrene cross-linked.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 329.00px; height: 260.20px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image46.png"
            style="width: 329.00px; height: 260.20px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Main problems relate to:</span></p>
<ol class="c14 lst-kix_list_4-0 start" start="1">
    <li class="c8 c23 li-bullet-0"><span class="c2">non-quantitative reactions.</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Incomplete orthogonality between the temporary blocking and
            permanent (which include the polymer link).</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">Side-reactions, especially at the final complete deprotection
            and cleavage from the carrier.</span></li>
</ol>
<p class="c8"><span class="c2">If any N-terminal residue of the peptide-polymer conjugate remains unacylated after
        any coupling stage, this causes incomplete and inaccurate sequences. Hence, extensive washing is carried out
        between each stage.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">In favourable cases, coupling can be pushed to very nearly 100% by use of excess
        acylating agent, or performing the stages more than once. The use of highly activated intermediates may be
        advantageous. Completeness can be monitored by colour tests for residual amino groups. Advanced separation
        and characterisation technology have been extremely helpful in dealing with the difficult purification
        problems.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">In the standard Merrifield approach, the differentiation between the temporary
    </span><span class="c3">&alpha;</span><span class="c2">-amino protection on the one hand, and the permanent
        side-chain protection and peptide-resin link on the other, is dependent on the much greater acid-lability of
        Boc groups than benzyl ester and related groups. The difference is perfectly sufficient for syntheses
        involving a modest number of steps, but slight side-chain deprotection of Lys(Z) residues can occur under
        Boc-cleavage conditions, leading to the formation of branched peptides, and some loss of peptide from the
        peptide-resin conjugate takes place at each Boc deprotection, because the benzyl ester anchor is not
        entirely resistant to acidolysis.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 348.40px; height: 316.73px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image47.png"
            style="width: 348.40px; height: 316.73px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c2">Many biologically active peptides have an amide function at the C-terminal.</span>
</p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 335.80px; height: 248.67px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image48.png"
            style="width: 335.80px; height: 248.67px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c4">Case-Study &ndash; Bradykinin</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 464.27px; height: 315.53px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image49.png"
            style="width: 464.27px; height: 315.53px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">The Sheppard Approach</span></p>
<p class="c8"><span class="c2">In 1971 Sheppard argued that it would be desirable for the polymeric carrier to be
        chemically similar to the growing peptide chain, so that both carrier and peptide could be well solvated by
        dipolar aprotic solvents, to give an open gel system in which there was free access of reagents to reactive
        sites. This was in contrast to the situation with peptides attached to Merrifield cross-linked polystyrenes,
        where the favoured solvent for swelling the polymeric matrix (DCM) was unable to solvate the conjugated
        peptide chain well and thereby encouraged its aggregation, reducing the availability of reactive groups.
        Hence, polyamide carriers were introduced. Fmoc protecting groups were also introduced in place of Boc for
        greater orthogonality.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c9">The standard Sheppard carrier is derived from a cross-linked polyacrylamide
        incorporating a number of sarcosine methyl ester side-chains. The side-chains are extended by treatment with
        ethylenediamine, followed by coupling with Fmoc-norleucine, which provides an internal reference amino acid.
        A &ldquo;linker&rdquo; group or resin &ldquo;handle&rdquo; is added after Fmoc cleavage, and the first
        protected residue of the peptide target is attached to the exposed hydroxy function on the linker. Alternate
        deprotection and coupling of Fmoc residues with acid-labile side-chain protection assembles the required
        sequence, which is then </span><span class="c3">&alpha;</span><span class="c2">-deprotected and detached
        from the carrier with simultaneous side-chain deprotection, by mild acidolysis.</span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 360.00px; height: 253.07px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image41.png"
            style="width: 360.00px; height: 253.07px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9">The acid-lability of the peptide-carrier link is due to the 4-alkoxybenzyl ester.
        Other options are available to suit. The </span><span class="c3">&alpha;</span><span class="c9">-Fmoc,
    </span><span class="c3">&omega;</span><span class="c9">-mild-acid-labile strategy has advantages over the
        Merrifield (</span><span class="c3">&alpha;</span><span class="c9">-Boc, </span><span
        class="c3">&omega;</span><span class="c2">-strong-acid-labile) in two ways:</span></p>
<ol class="c14 lst-kix_list_5-0 start" start="1">
    <li class="c8 c23 li-bullet-0"><span class="c9">the </span><span class="c3">&alpha;</span><span
            class="c9">/</span><span class="c3">&omega;</span><span class="c2">&nbsp;protection is absolutely
            orthogonal</span></li>
    <li class="c8 c23 li-bullet-0"><span class="c2">the final deprotection can be carried out under much gentler
            conditions.</span></li>
</ol>
<p class="c8"><span class="c2">Furthermore, a single solvent, DMF, is generally used at all stages, reducing the
        number of washes needed, and avoiding difficulties due to swelling and contraction of the polymer with
        solvent.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">A common and serious problem in solid phase synthesis arises from the tendency of
        certain sequences to self-aggregate on the resin. This reduces the accessibility of the N-terminal group to
        reactants in solution, which interferes with coupling, deprotection, and monitoring methods based on
        end-group detection. The problem usually appears after six or seven residues have been added, when it
        becomes necessary to use extended reaction times, repeated reaction cycles, extremely reactive acylating
        agents, or aggregation-disrupting media in order to continue chain assembly. It is difficult to predict when
        this will happen (or not).</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c4">Case Studies</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c6">Acyl Carrier Protein-(65-74)-decapeptide</span></p>
<p class="c8"><span class="c2">Synthesised by Sheppard Method where the Merrifield failed, probably because of
        aggregation-related phenomena. Uses pentafluorophenyl ester activation.</span></p>
<p class="c5"><span class="c2"></span></p><a id="t.31a429cd1ce303f79d01059ecb9af4c65a3904f4"></a><a id="t.3"></a>
<table class="c7">
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Carrier</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">As above</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c17">N(</span><span class="c29 c17">&alpha;</span><span
                    class="c0">)-Protection</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Fmoc</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Side-chain protection</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c17">Asp(OBu</span><span class="c31">t</span><span class="c17">),
                    Tyr(</span><span class="c31">t</span><span class="c0">Bu)</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Attachment of the first residue</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c17">(FmocGly)</span><span class="c39">2</span><span class="c0">O / DMAP /
                    DMF</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c17">N(</span><span class="c29 c17">&alpha;</span><span
                    class="c0">)-deprotection</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">20% piperidine in DMF</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Coupling</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">FmocXaaOPfp / DMF, with catalysis by HOBt in some cases</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c33" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Cleavage from carrier and side chain deprotection</span></p>
        </td>
        <td class="c21" colspan="1" rowspan="1">
            <p class="c8"><span class="c0">Fmoc removal as usual, then 95% aq. TFA.</span></p>
        </td>
    </tr>
</table>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c3 c27">&beta;</span><span class="c6">-amyloid (1-43) peptide</span></p>
<p class="c5"><span class="c2"></span></p><a id="t.c75489f4ab9902d484f9f687956885e1655e553a"></a><a id="t.4"></a>
<table class="c7">
    <tr class="c12">
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Starting Material</span></p>
        </td>
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">FmocThr(Bu</span><span class="c13">t</span><span class="c9">)-Pepsyn KA,
                    i.e. FmocThr(Bu</span><span class="c13">t</span><span class="c2">) esterified to a
                    4-alkoxybenzyl alcohol, which was linked through the alkoxy group to a norleucine residue, and
                    thence to a polydimethylacrylamide.</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">N(</span><span class="c3">&alpha;</span><span class="c2">)-protection
                </span></p>
        </td>
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Fmoc</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Side-chain protection</span></p>
        </td>
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">Lys(Boc), Ser(Bu</span><span class="c13">t</span><span class="c9">),
                    Thr(Bu</span><span class="c13">t</span><span class="c9">), Tyr(Bu</span><span
                    class="c13">t</span><span class="c2">), Gln(Trt), His(Trt), Arg(Mtr)</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">N(</span><span class="c3">&alpha;</span><span
                    class="c2">)-deprotection</span></p>
        </td>
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">20% piperidine in DMF</span></p>
        </td>
    </tr>
    <tr class="c12">
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c2">Coupling</span></p>
        </td>
        <td class="c20" colspan="1" rowspan="1">
            <p class="c8"><span class="c9">FmocXaaOPfp / DMF in most cases, except after an Hmb-residue, when a Fmoc
                    NCA/CH</span><span class="c1">2</span><span class="c9">Cl</span><span class="c1">2</span><span
                    class="c2">&nbsp;was used to add the next residue</span></p>
        </td>
    </tr>
</table>
<p class="c5"><span class="c2"></span></p>
<p class="c11"><span
        style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 380.93px; height: 323.53px;"><img
            alt="" src="https://storage.googleapis.com/alchemyst-assets/docs/organic/peptides/image42.png"
            style="width: 380.93px; height: 323.53px; margin-left: -0.00px; margin-top: -0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
            title=""></span></p>
<p class="c8"><span class="c9 c22 c16">Comparison of Solid Phase &amp; Solution Synthesis</span></p>
<p class="c8"><span class="c2">Generally speaking, Solid Phase Synthesis is adopted for medium sizes (Sheppard
        generally predominating), while proteins are assembled in solution from fragments made by Solid Phase
        methods.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c8"><span class="c2">Solution Synthesis is harder to wash, as in the Solid anything not attached to the
        polymer chain is washed away, giving a purer product. However, for the solid, must ensure 100% protection /
        deprotection at each step, otherwise missing residues attach.</span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c5"><span class="c2"></span></p>
<p class="c5"><span class="c2"></span></p>